Bedaquiline: how better to use it

Eur Respir J. 2017 Nov 9;50(5):1701670. doi: 10.1183/13993003.01670-2017. Print 2017 Nov.

Authors

Jose A Caminero^{1

2}, Alberto Piubello^{2

3}, Anna Scardigli⁴, Giovanni Battista Migliori⁵

Affiliations

¹ Pneumology Dept, Hospital General de Gran Canaria "Dr. Negrin", Las Palmas de GC, Spain.
² Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
³ MDR-TB Division, Damien Foundation, Brussels, Belgium.
⁴ The Global Fund to Fight Aids, Tuberculosis and Malaria, Geneva, Switzerland.
⁵ Maugeri Care and Research Institute, IRCCS, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.

PMID: 29122921
DOI: 10.1183/13993003.01670-2017

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents
Diarylquinolines*
Humans
Tuberculosis, Multidrug-Resistant*

Substances

Antitubercular Agents
Diarylquinolines
bedaquiline